抑制GALNT7通过失活AKT通路抑制非小细胞肺癌细胞增殖与侵袭并促进凋亡
本研究在A549和NCI-H1650非小细胞肺癌细胞中转染靶向GALNT7的siRNA,观察对细胞增殖、凋亡和侵袭的影响,并探究AKT通路的中介作用。结果显示抑制GALNT7可降低细胞增殖与侵袭、增加凋亡,且伴随p-AKT/AKT表达下降;加入AKT激活剂740 Y-P可逆转上述效应。结论提示GALNT7抑制通过失活AKT通路发挥抗肿瘤作用。
要点
- 抑制GALNT7可降低非小细胞肺癌细胞增殖与侵袭并促进凋亡。
- GALNT7抑制伴随AKT磷酸化水平下降。
- AKT激活剂740 Y-P可逆转GALNT7抑制的细胞效应。
核心结论
- 抑制GALNT7通过失活AKT通路抑制非小细胞肺癌细胞增殖与侵袭并增加凋亡。
研究设计与样本
- 将阴性对照siRNA(si-NC)和靶向GALNT7的siRNA(si-GALNT7)转染至A549和NCI-H1650细胞。
- 随后在转染或未转染细胞中加入AKT激活剂740 Y-P进行处理。
主要发现
- 与si-NC转染相比,si-GALNT7转染后A549细胞在24小时、48小时和72小时的增殖减少,NCI-H1650细胞在48小时和72小时的增殖减少。
- 与si-NC转染相比,si-GALNT7转染后A549和NCI-H1650细胞的凋亡率增加、侵袭细胞数减少。
- 与si-NC转染相比,si-GALNT7转染后A549和NCI-H1650细胞的p-AKT/AKT表达降低。
- 加入740 Y-P可抑制si-GALNT7转染对上述细胞增殖、凋亡和侵袭的影响。
临床怎么用
- 提示GALNT7-AKT轴可能作为非小细胞肺癌的潜在干预靶点,但尚需进一步转化研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective Polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) is a glycopeptide transferase which is closely involved in the development and progression of cancer. This study aimed to investigate the effects of GALNT7 inhibition on non-small cell lung cancer (NSCLC) cell proliferation, apoptosis and invasiveness and to determine whether these effects are mediated by the protein kinase B (AKT) pathway. Methods Negative control small interfering RNA (siRNA) (si-NC) and siRNA targeting GALNT7 (si-GALNT7) were transfected into A549 and NCI-H1650 cells. Afterwards, the AKT activator ‘740 Y-P’ was added to treat the cells with or without siRNA transfection. Results Cell proliferation was reduced after si-GALNT7 transfection compared with si-NC transfection at 24 hours, 48 hours and 72 hours in A549 cells, and at 48 hours and 72 hours in NCI-H1650 cells. Furthermore, the cell apoptosis rate was increased, but the cell invasive number was decreased after si-GALNT7 transfection compared with si-NC transfection in A549 cells and NCI-H1650 cells. Phosphorylated (p)-AKT/AKT expression was lower after si-GALNT7 transfection compared with si-NC transfection in A549 cells and NCI-H1650 cells. Worth noting, the effects of si-GALNT7 transfection on the above-mentioned cell proliferation, apoptosis and invasiveness were repressed by the addition of 740 Y-P in A549 cells and NCI-H1650 cells. Conclusion GALNT7 inhibition suppresses NSCLC cell proliferation and invasiveness while increasing apoptosis through inactivation of the AKT pathway.
引用
- BMJ Open Respiratory Research:Inhibition of GALNT7 suppresses cell proliferation and invasiveness while elevating cell apoptosis via the inactivation of the AKT pathway in non-small cell lung cancer
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。